|
|
 Previous Article | Table of Contents | Next Article 
Administration of recombinant human interleukin-7 alters the frequency and
number of myeloid progenitor cells in the bone marrow and spleen of mice
G Damia, KL Komschlies, CR Faltynek, FW Ruscetti and RH Wiltrout
Laboratory of Experimental Immunology, NCI-FCRDC, Frederick, MD 21702-
1201.
The administration of greater than or equal to 5 micrograms interleukin- 7
(IL-7) twice a day to mice for 4 to 7 days increased by twofold to fivefold
the total number of splenic and peripheral blood leukocytes, but did not
appreciably increase bone marrow (BM) cellularity. This regimen of IL-7
administration also resulted in a greater than 90% reduction in the
frequency and total number of single lineage colony- forming unit-culture
(CFU-c) and multilineage CFU-granulocyte, erythroid, monocyte,
megakaryocyte colonies that could be cultured from the BM, but a fivefold
to 15-fold increase in the number of these progenitors that could be
cultured from the spleen. All of these effects were reversible with
progenitor and white blood cell numbers returning to near normal by day 6.
Morphologic analysis of cells obtained from the BM of IL-7-treated mice
showed an increase in lymphoid cells. Surface phenotype analysis showed
that most of this IL- 7-induced increase in lymphocytes was attributable to
an increase in immature B cells (B220+, sIg-), while cells expressing the
myelomonocytic markers 8C5 and MAC-1 decreased by twofold to threefold.
Further studies showed that the administration of IL-7 to mice that had
been rendered leukopenic by the injection of cyclophosphamide (Cy) or 5-
fluorouracil (5FU) exhibited a more rapid recovery and/or overshoot in
their peripheral blood lymphocytes when compared with mice treated with Cy
or 5FU alone. These results show that IL-7 can differentially regulate
myelopoiesis in the BM and spleen, while stimulating lymphopoiesis.
Volume 79,
Issue 5,
pp. 1121-1129,
03/01/1992
Copyright © 1992 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
F. B. Aiello, J. R. Keller, K. D. Klarmann, G. Dranoff, R. Mazzucchelli, and S. K. Durum
IL-7 Induces Myelopoiesis and Erythropoiesis
J. Immunol.,
February 1, 2007;
178(3):
1553 - 1563.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Ueda, K. Yang, S. J. Foster, M. Kondo, and G. Kelsoe
Inflammation Controls B Lymphopoiesis by Regulating Chemokine CXCL12 Expression
J. Exp. Med.,
January 5, 2004;
199(1):
47 - 58.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Storek, T. Gillespy III, H. Lu, A. Joseph, M. A. Dawson, M. Gough, J. Morris, R. C. Hackman, P. A. Horn, G. E. Sale, et al.
Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys
Blood,
May 15, 2003;
101(10):
4209 - 4218.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Dainiak, J. K. Waselenko, J. O. Armitage, T. J. MacVittie, and A. M. Farese
The Hematologist and Radiation Casualties
Hematology,
January 1, 2003;
2003(1):
473 - 496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. J. Fry and C. L. Mackall
Interleukin-7: from bench to clinic
Blood,
May 13, 2002;
99(11):
3892 - 3904.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Welniak, A. R. Khaled, M. R. Anver, K. L. Komschlies, R. H. Wiltrout, S. Durum, F. R. Ruscetti, B. R. Blazar, and W. J. Murphy
Gastrointestinal Cells of IL-7 Receptor Null Mice Exhibit Increased Sensitivity to Irradiation
J. Immunol.,
March 1, 2001;
166(5):
2923 - 2928.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Geiselhart, C. A. Humphries, T. A. Gregorio, S. Mou, J. Subleski, and K. L. Komschlies
IL-7 Administration Alters the CD4:CD8 Ratio, Increases T Cell Numbers, and Increases T Cell Function in the Absence of Activation
J. Immunol.,
March 1, 2001;
166(5):
3019 - 3027.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Liu, J. Poursine-Laurent, and D. C. Link
Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF
Blood,
May 15, 2000;
95(10):
3025 - 3031.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. J. Grossman, J. W. Verbsky, L. Yang, L. J. Berg, L. E. Fields, D. D. Chaplin, and L. Ratner
Dysregulated Myelopoiesis in Mice Lacking Jak3
Blood,
August 1, 1999;
94(3):
932 - 939.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Kapp, M. Bhatia, D. Bonnet, B. Murdoch, and J. E. Dick
Treatment of Non-Obese Diabetic (NOD)/Severe-Combined Immunodeficient Mice (SCID) With flt3 Ligand and Interleukin-7 Impairs the B-Lineage Commitment of Repopulating Cells After Transplantation of Human Hematopoietic Cells
Blood,
September 15, 1998;
92(6):
2024 - 2031.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. A. Young, D. M. Klinman, D. A. Reynolds, K. J. Grzegorzewski, A. Nii, J. M. Ward, R. T. Winkler-Pickett, J. R. Ortaldo, J. J. Kenny, and K. L. Komschlies
Bone Marrow and Thymus Expression of Interferon-gamma Results in Severe B-Cell Lineage Reduction, T-Cell Lineage Alterations, and Hematopoietic Progenitor Deficiencies
Blood,
January 15, 1997;
89(2):
583 - 595.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
